Global Research: 11-02-2026, The global expansion of high-containment biolabs without oversight — increasingly engaged in Nipah virus research — combined with aggressive patent consolidation of Nipah’s core glycoproteins and their integration into mRNA and self-amplifying mRNA (saRNA) injection platforms, represents a profound and … The post The Next Plandemic: 3,625 Biolabs, Nipah Virus Patents, and Self-Amplifying mRNA Injections appeared first on Global Research . » Lees verder
